Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:46 PM
Ignite Modification Date:
2025-12-24 @ 7:46 PM
NCT ID:
NCT07124403
Eligibility Criteria:
Inclusion Criteria:
* Signed written informed consent
* Affiliation to the Social Security System
* Patients with breast or digestive cancer for whom a fluoroptmidine therapy is being considered
* OR Patients on dialysis (GFR \< 10 ml/min/1.73 m²)
* OR Nephrology patients with IR
Exclusion Criteria:
* Patient with anemia \< 8.5 g/dl
* Patient with LDH \> 2 x \> ULN
* Legal incapacity or limited legal capacity
* Subject without health insurance
* Subject in the exclusion period of another study or in the "national volunteer file"
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07124403
Study Brief:
Protocol Section:
NCT07124403